Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

Merck will share new scientific findings from its HIV clinical development programs, including Phase 2 data on the safety and pharmacokinetics of MK-8527, an investigational, novel nucleoside reverse ...

The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight ...

Discover how understanding your viral load and CD4 count puts you in control of HIV treatment and transforms confusing ...

Elton John: We've made great progress on HIV/AIDS. Budget cuts threaten to set us back. Programs that provide treatment, fuel prevention and fight the stigma of HIV/AIDS should be expanded, not ...

The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly ...

A class of HIV drugs known as nucleotide reverse transcriptase inhibitors (NRTIs) may help prevent Alzheimer’s disease, reducing risk by up to 13%, a new study suggests.

A class of HIV drugs known as nucleotide reverse transcriptase inhibitors (NRTIs) may help prevent Alzheimer’s disease, reducing risk by up to 13%, a new study suggests.

HIV medications help people with HIV lead longer, healthier lives. They're an essential part of taking care of yourself. But AIDS and HIV drug side effects are also common. These side effects ...

When growing gang violence and the kidnappings of healthcare workers forced Haiti’s leading organization in the treatment of HIV and AIDS-related illnesses to relocate operations from its main ...

Harvard Pilgrim Health Care reversed a decision to stop covering certain HIV medications to Mainers, news of which created anxiety and confusion during the state’s open enrollment period.

A groundbreaking antipsychotic, a powerful new antibiotic, and a vaccine-like prophylactic for HIV are some of the most important drugs to have arrived this year.